"Designing Growth Strategies is in our DNA"

Udder Health Market Size, Share, and Industry Analysis, By Product Type (Therapeutics {Drugs, Vaccines, and Others}, and Diagnostics), By Animal Type (Dairy Cattle and Others), and By End-User (Dairy Farms and Veterinary Clinics & Hospitals), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI114823

 

Udder Health Market Size & Future Outlook

The global udder health market size was valued at USD 1.29 billion in 2025. The market is projected to grow from USD 1.38 billion in 2026 to USD 2.38 billion by 2034, exhibiting a CAGR of 7.00% during the forecast period.

The global udder health market is witnessing significant growth due to an increasing global demand for dairy products that require good udder health of dairy animals. Ensuring the health of dairy cattle has become a priority for farmers, veterinarians, and dairy industry stakeholders. Udder health is critical for maintaining milk quality, animal welfare, and the overall productivity of dairy farms. 

  • For instance, according to the data published by the World Wildlife Fund, millions of farmers worldwide tend to use approximately 270 million dairy cows to produce milk. Such a large number of cows require udder health products to maintain their health and milk quality. 

Moreover, the presence of key market players with broad product offerings in therapeutics and diagnostics for udder health also boosted the growth of the market during the forecast period.

Udder Health Market Driver

Increasing Incidence of Bovine Mastitis and Increasing Burden on Farmers to Drive Market Growth

The rising incidence of bovine mastitis is propelling the growth of the global udder health market. Mastitis, primarily caused by bacterial infections, reduces milk yield and quality. This disease, which affects dairy cattle worldwide, leads to substantial economic losses due to decreased milk production, increased treatment costs, and compromised milk quality. 

  • For example, data from Improve International stated that in 2021, approximately 30 out of every 100 cows were affected by mastitis, resulting in costs of around USD 12,771.4 per year for farmers, leading to premature culling and financial strain. The high number of affected cattle led increasing demand for adequate diagnostics and treatment by cattle owners.

Moreover, to mitigate these impacts, dairy farmers are increasingly adopting advanced diagnostics, innovative treatments, and preventive strategies to manage udder health, thereby boosting demand for udder health products and services and fueling market growth.

Cow Milk Production per World Region (%), 2022

According to the International Dairy Federation, 881 million tons of milk were produced globally in 2019, and Asia held the largest share in milk production, around 32.0% of the total.

Udder Health Market Restraint

Limited Adoption of Advanced Diagnostic Technologies in Lower-Economic-Countries to Hamper Market Growth

One significant restraint in the udder health market is the high cost of advanced udder health solutions. This barrier limits the adoption of technologies such as automated mastitis detection systems and advanced diagnostic tools, particularly among small-scale dairy farmers. 

  • For example, in countries such as Mexico, many farmers cannot afford these technologies due to limited financial resources and inadequate infrastructure. This restricts their ability to implement effective udder health management strategies.

Udder Health Market Opportunity

Increasing Awareness Programs to Offer Potential Growth Opportunity to Market 

Increasing awareness programs for udder health offer significant growth opportunities by promoting better practices and technologies. These programs can educate dairy farmers about the importance of regular udder health monitoring, proper milking routines, and hygiene practices to prevent mastitis.

  • In June 2024, CVS Farm launched a dairy cow mastitis campaign with an aim to enhance diagnostic testing and reduce unnecessary antibiotic use by targeting treatments only where needed, thereby mitigating antimicrobial resistance. Such programs boost the growth of the udder health market during the forecast period.

Key Insights

The report covers the following key insights:

  • Epidemiology of Bovine Mastitis
  • Overview: Udder Health 
  • Key Industry Developments - Mergers, Acquisitions, Partnerships, and Launches. 
  • Impact of COVID-19 on the Market

Segmentation

By Product Type By Animal Type By End-User By Region
  • Therapeutics
  • Drugs
  • Vaccines 
  • Others
  • Diagnostics
  • Dairy Cattle
  • Others
  • Dairy Farms
  • Veterinary Clinics & Hospitals
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Analysis by Product Type 

By product type, the market is divided into therapeutics (drugs, vaccines, and others) and diagnostics.

The diagnostics segment is expected to hold a significant portion of the market. Owing to the rising demand for early detection of the disease in dairy animals, the overall burden on farmers is reduced, and the quality of milk is maintained. In addition, the presence of key players with advanced product launches promotes segment growth in the market.

  • For instance, in August 2023, Zoetis Inc. introduced Vetscan Mastigram+, a rapid diagnostic tool for detecting mastitis pathogens in dairy cows. This technology helps farmers quickly identify infections, improving udder health management. Such launches promote the segment’s growth in the market.

Analysis by Animal Type

By animal type, the market is divided into dairy cattle and others.

Dairy cattle are expected to dominate a significant portion of the udder health market due to the increasing demand for milk and dairy products. This heightened demand necessitates rigorous udder health maintenance to ensure both quality and yield. 

  • For instance, according to the Dairy and Products Annual Report 2023, in India, Buffalo milk production in 2024 was forecasted to be 110.7 million metric tons, which represents an increase of nearly two percent from 2023. Also, buffalo held 32.0% of all species for milk production in India. Such scenarios increase the demand for udder health for dairy cattle and thus promote the segment’s growth in the market.

Analysis by End-User

By end-user, the market is divided into dairy farms and veterinary clinics & hospitals. 

Veterinary clinics & hospitals are capturing a significant share of the udder health market due to the increasing demand for specialized care in managing udder-related issues. The rising number of veterinarians and their expertise in diagnosing and treating conditions such as mastitis are boosting the growth of the segment.

  • For instance, in 2023, according to the Veterinary Council of India (VCI), there will be 81,938 Registered Veterinary Practitioners in India 2023. Such scenarios boost the treatment of dairy animals in these settings and propel market growth.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization   to gain extensive market insights.

North America accounted for a substantial share of the global udder health market in 2024. The region's growth is amplified by the presence of advanced facilities for animal health and the increasing number of regulatory policies for maintaining the quality of milk and dairy products.

  • For instance, in March 2024, the U.S. Department of Agriculture (USDA), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC) announced the investigation for an illness among dairy cows that is causing decreased lactation, low appetite, and other symptoms for avian influenza, such stringent policies for maintain dairy cows health and production, eventually increase the demand for udder health products in the market.

On the other hand, Europe held a considerable share of the udder health market. The growth of the region is due to the strong presence of key players and expanded focus on strategic activities, promoting the growth of the market in the region.

  • For instance, in July 2023, Mastaplex Ltd and Vetoquinol extended their exclusive distribution agreement for Mastatest. This innovative product is designed to diagnose bovine mastitis and is now distributed across major European dairy markets. The agreement aimed to enhance the availability of Mastatest, which provides rapid and accurate diagnostic results to support effective mastitis management. Such activities boost the region's market growth.

Moreover, Asia Pacific is expected to grow notably during the forecast period. The growth of the region is attributed to the increasing production and demand for milk products and the rising number of diseases in cattle, leading to a boost in the demand for udder health products in the market.

Key Players Covered

The global udder health market is semi-consolidated with a small number of groups and standalone providers. The report includes the profiles of the following key players:

  • Merck & Co., Inc. (U.S.)
  • Vetoquinol (France)
  • Zoetis Services LLC (U.S.)
  • Elanco (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Phibro Animal Health Corporation (U.S.)
  • Pecus Healthcare Pvt Ltd (India)
  • EIO Diagnostics Inc. (U.S.)
  • Udder Health Systems (U.S.)

Key Industry Developments

  • In October 2024, Phibro Animal Health Corporation acquired Zoetis Services LLC's medicated feed additives portfolio.
  • In April 2021, Boehringer Ingelheim International GmbH. Introduced Ubroseal Blue, an internal teat sealant, as part of its mastitis prevention portfolio. Ubroseal Blue joins Ubrostar and Bovikalc Dry in the company's dry cow management offerings, aiming to prevent new intramammary infections during the dry period. 


  • 2021-2034
  • 2025
  • 2021-2024
  • 180
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann